Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Nanopreparations For Oral Administration

D. Hubbard, D. Brayden, H. Ghandehari
Published 2014 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1093/JAC/DKH411
Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis.
A. Sharma (2004)
10.1016/j.ejpb.2011.09.012
Twenty years of drug nanocrystals: where are we, and where do we go?
R. Mueller (2012)
10.1021/JM0000564
QSAR Model for Drug Human Oral Bioavailability1
Fumitaka Yoshida† and (2000)
10.1016/J.JCONREL.2007.04.004
Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery.
X. Y. Xiong (2007)
10.1016/S0939-6411(03)00157-7
Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation.
M. Roldo (2004)
Early intestinal microparticle uptake in the rat.
R. A. Hazzard (1996)
10.1016/J.IJPHARM.2005.01.022
Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium.
Nazila Salamat-Miller (2005)
10.1136/gut.29.8.1035
Measurement of gastrointestinal pH profiles in normal ambulant human subjects.
D. F. Evans (1988)
10.1002/JPS.21155
Enhanced oral bioavailability of doxorubicin in a dendrimer drug delivery system.
Weilun Ke (2008)
10.1023/A:1018888927852
Body Distribution of Camptothecin Solid Lipid Nanoparticles After Oral Administration
Shicheng Yang (2004)
10.1023/A:1016030202104
Lectin-bearing Polymerized Liposomes as Potential Oral Vaccine Carriers
Hongming Chen (2004)
10.1016/J.JCONREL.2005.02.010
Enhancement of oral bioavailability of poorly water-soluble drugs by poly(ethylene glycol)-block-poly(alkyl acrylate-co-methacrylic acid) self-assemblies.
V. Sant (2005)
10.1039/9781849735292
Nanostructured biomaterials for overcoming biological barriers
M. Alonso (2012)
10.1023/A:1018967116988
Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)
P. Artursson (2004)
Tissue concentration of nanoencapsulated radio-labelled cyclosporin following peroral delivery in mice or ophthalmic application in rabbits
S. Bonduelle (1996)
10.1002/CHIN.197825228
′CASCADE′- AND ′NONSKID-CHAIN-LIKE′ SYNTHESES OF MOLECULAR CAVITY TOPOLOGIES
E. Buhleier (1978)
10.1023/A:1016366022712
Molecular Weights of Free and Drug-Loaded Nanoparticles
Luc Vansnick (2004)
10.1016/S0169-409X(98)00039-8
Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics.
Allémann (1998)
10.1016/j.ejpb.2010.06.007
Polymeric micelles for oral drug delivery.
G. Gaucher (2010)
The absolute oral bioavailability of selected drugs
Sietsema Wk (1989)
10.1023/A:1015992819290
Enhancement of Colonic Drug Absorption by the Transcellular Permeation Route
M. Tomita (2004)
10.1016/j.jconrel.2008.09.089
The influence of bile acids on the oral bioavailability of vitamin K encapsulated in polymeric micelles.
P. V. van Hasselt (2009)
10.1007/BF01870332
Morphological factors influencing transepithelial permeability: A model for the resistance of theZonula Occludens
P. Claude (2005)
10.1002/JPS.2600751009
Disposition kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate nanoparticles.
P. Maincent (1986)
10.1016/S0378-5173(98)00394-9
Vitamin B12-mediated transport of nanoparticles across Caco-2 cells.
G. J. Russell-Jones (1999)
10.1016/S0378-5173(03)00271-0
Thiolated polymers--thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates.
A. Bernkop-Schnürch (2003)
10.1201/9781003067542
Microparticulate systems for the delivery of proteins and vaccines
S. Cohen (1996)
10.1002/jps.21262
A comparison of the effect of chitosan and chitosan-coated vesicles on monolayer integrity and permeability across Caco-2 and 16HBE14o-cells.
L. Kudsiova (2008)
10.5772/54944
Nanoparticles Based on Chitosan Derivatives
Y. Zambito (2013)
10.1007/s11095-004-1188-0
Engineering Polysaccharide-Based Polymeric Micelles to Enhance Permeability of Cyclosporin A Across Caco-2 Cells
M. Francis (2004)
10.1211/0022357044427
Pluronic block copolymers and Pluronic poly(acrylic acid) microgels in oral delivery of megestrol acetate
V. Alakhov (2004)
10.1517/17425247.2011.539200
Vitamin B12 in drug delivery: breaking through the barriers to a B12 bioconjugate pharmaceutical
Susan M. Clardy (2011)
10.1016/J.IJANTIMICAG.2004.07.010
Chemotherapeutic efficacy of poly (DL-lactide-co-glycolide) nanoparticle encapsulated antitubercular drugs at sub-therapeutic dose against experimental tuberculosis.
A. Sharma (2004)
Biodegradable microparticles as controlled release antigen delivery systems.
D. O'hagan (1991)
10.1007/BF02209146
Physiological regulation of transepithelial impedance in the intestinal mucosa of rats and hamsters
J. Pappenheimer (2005)
10.1016/J.JCONREL.2005.11.012
Intestinal uptake and biodistribution of novel polymeric micelles after oral administration.
Frédéric Mathot (2006)
10.1517/17425240902870413
Poly(alkycyanoacrylate) nanoparticles for enhanced delivery of therapeutics – is there real potential?
A. Graf (2009)
10.1023/B:PHAM.0000003379.76417.3e
Uptake of Chitosan and Associated Insulin in Caco-2 Cell Monolayers: A Comparison Between Chitosan Molecules and Chitosan Nanoparticles
Zengshuan Ma (2004)
A new nanocapsule formulation with hydrophilic core : Application to the oral administration of salmon calcitonin in rats
H. Vranckx (1996)
10.1155/2012/750891
Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery
P. Severino (2012)
10.1016/S0378-5173(03)00158-3
Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor.
H. Li (2003)
10.1016/J.IJPHARM.2005.05.027
Nano-encapsulation of azole antifungals: potential applications to improve oral drug delivery.
R. Pandey (2005)
10.1208/s12249-010-9561-2
Recent Advancement of Chitosan-Based Nanoparticles for Oral Controlled Delivery of Insulin and Other Therapeutic Agents
Anumita Chaudhury (2010)
10.1016/S0378-5173(96)04690-X
Vitamin B12-mediated uptake of erythropoietin and granulocyte colony stimulating factor in vitro and in vivo
A. D. Habberfield (1996)
10.1016/s0169-409x(96)00423-1
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.
C. Lipinski (2001)
Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives
Melike Üner (2007)
10.1021/mp900191s
Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access.
E. Collnot (2010)
10.1021/JM020017N
Molecular properties that influence the oral bioavailability of drug candidates.
D. Veber (2002)
10.1021/BM0607776
Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery.
Yu-Hsin Lin (2007)
10.1016/j.ijpharm.2009.04.026
Lipid nanocapsules: a new platform for nanomedicine.
N. Huynh (2009)
10.1016/J.TUBE.2003.07.001
Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis.
R. Pandey (2003)
10.1023/A:1011964213024
Effects of Pluronic Block Copolymers on Drug Absorption in Caco-2 Cell Monolayers
E. Batrakova (2004)
10.1016/j.ijpharm.2013.02.030
Approaches for enhancing oral bioavailability of peptides and proteins.
J. Renukuntla (2013)
10.1200/JCO.1997.15.1.110
Patient preferences for oral versus intravenous palliative chemotherapy.
G. Liu (1997)
10.1016/0142-9612(84)90002-4
Degradation of poly (isobutyl cyanoacrylate) nanoparticles.
V. Lenaerts (1984)
10.1002/wnan.15
Synthesis of poly(alkyl cyanoacrylate)-based colloidal nanomedicines.
J. Nicolas (2009)
10.1016/j.jconrel.2010.11.022
G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity.
Deborah S. Goldberg (2011)
10.1038/nrd1632
Recent advances with liposomes as pharmaceutical carriers
V. Torchilin (2005)
10.1021/ar200234q
pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications.
H. Sung (2012)
10.1021/BC00034A016
Vitamin B12 mediated oral delivery systems for granulocyte-colony stimulating factor and erythropoietin.
G. J. Russell-Jones (1995)
10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
Use of chitosan as a biomaterial: studies on its safety and hemostatic potential.
S. B. Rao (1997)
10.1016/S0378-5173(02)00486-6
Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo.
Yan Pan (2002)
10.1021/mp700089s
Endocytosis inhibitors prevent poly(amidoamine) dendrimer internalization and permeability across Caco-2 cells.
Kelly M. Kitchens (2008)
10.1021/mp300436c
Evidence of oral translocation of anionic G6.5 dendrimers in mice.
G. Thiagarajan (2013)
10.1016/S0169-409X(98)00040-4
Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract.
Ponchel (1998)
10.1021/bc100094z
Carboxyl-terminated PAMAM-SN38 conjugates: synthesis, characterization, and in vitro evaluation.
N. Vijayalakshmi (2010)
10.1007/s11095-006-9122-2
Transport of Poly(Amidoamine) Dendrimers across Caco-2 Cell Monolayers: Influence of Size, Charge and Fluorescent Labeling
Kelly M. Kitchens (2006)
10.3109/17435390.2011.604442
Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles
K. Greish (2012)
10.1016/j.ejpb.2012.02.009
Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose.
M. Niu (2012)
10.1016/j.jconrel.2008.01.018
Polymeric micelles in oral chemotherapy.
L. Bromberg (2008)
10.2337/diab.37.2.246
New Approach for Oral Administration of Insulin With Polyalkylcyanoacrylate Nanocapsules as Drug Carrier
C. Damgé (1988)
10.3109/00365529409092497
Bidirectional small-intestinal permeability in the rat to some common marker molecules in vitro.
N. Pantzar (1994)
10.1016/j.biomaterials.2011.10.075
Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
Y. Jin (2012)
10.1166/JNN.2006.411
Preparation and characterization of insulin nanoparticles employing chitosan and poly(methylmethacrylate/methylmethacrylic acid) copolymer.
Ming-guang Li (2006)
10.1073/pnas.0608611104
Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus
S. Lai (2007)
10.1201/9780203748572
Lymphatic Transport of Drugs
W. Charman (1992)
10.1038/nrd1494
Nanosuspensions in drug delivery
Barrett E. Rabinow (2004)
10.1038/nrc1958
Polymer conjugates as anticancer nanomedicines
R. Duncan (2006)
10.1016/J.PROGPOLYMSCI.2012.04.004
Strategies for effective oral insulin delivery with modified chitosan nanoparticles: A review
Piyasi Mukhopadhyay (2012)
10.1080/10611860701603372
Design aspects of poly(alkylcyanoacrylate) nanoparticles for drug delivery
C. Vauthier (2007)
10.2147/IJN.S595
Nanocrystal technology, drug delivery and clinical applications
Jens-Uwe A. H. Junghanns (2008)
10.1016/S0168-3659(98)00097-2
Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery.
F. Maclaughlin (1998)
10.1016/J.ADDR.2007.05.003
Nanosizing--oral formulation development and biopharmaceutical evaluation.
F. Kesisoglou (2007)
10.1007/s11095-010-0153-3
Cellular Entry of G3.5 Poly (amido amine) Dendrimers by Clathrin- and Dynamin-Dependent Endocytosis Promotes Tight Junctional Opening in Intestinal Epithelia
Deborah S. Goldberg (2010)
10.1016/S0928-0987(02)00251-8
Nanosizing: a formulation approach for poorly-water-soluble compounds.
E. Merisko-Liversidge (2003)
10.1016/S0939-6411(02)00162-5
In vitro evaluation of the viscoelastic properties of chitosan-thioglycolic acid conjugates.
Margit D Hornof (2003)
10.1016/j.ijpharm.2010.07.044
Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives.
R. Shegokar (2010)
10.1007/s11095-007-9367-4
Alginate/Chitosan Nanoparticles are Effective for Oral Insulin Delivery
B. Sarmento (2007)
10.1016/J.JCONREL.2005.01.001
Trimethylated chitosans as non-viral gene delivery vectors: cytotoxicity and transfection efficiency.
T. Kean (2005)
10.1021/BM0703923
Oral bioavailability of insulin contained in polysaccharide nanoparticles.
B. Sarmento (2007)
10.1016/j.addr.2011.07.004
Spiral progression in the development of absorption enhancers based on the biology of tight junctions.
M. Kondoh (2012)
10.1038/nnano.2008.114
Seven challenges for nanomedicine.
W. Sanhai (2008)
10.1016/j.jconrel.2010.02.001
A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Abdallah Makhlof (2011)
10.1016/J.JCONREL.2006.05.013
Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation.
F. Cui (2006)
10.1021/BM060307B
Hydrotropic polymeric micelles for enhanced paclitaxel solubility: in vitro and in vivo characterization.
S. Lee (2007)
10.1016/S0928-0987(97)10007-0
Binding and uptake of biodegradable poly-DL-lactide micro- and nanoparticles in intestinal epithelia.
S. McClean (1998)
10.1016/S0168-3659(99)00237-0
Oral uptake and translocation of a polylysine dendrimer with a lipid surface.
A. Florence (2000)
10.1007/BF00275265
Role of zinc in insulin biosynthesis
S. Emdin (2004)
10.1016/S0168-3659(03)00160-3
Potentiality of double liposomes containing salmon calcitonin as an oral dosage form.
Kenji Yamabe (2003)
10.1023/A:1026166729873
Engineering of Dendrimer Surfaces to Enhance Transepithelial Transport and Reduce Cytotoxicity
R. Jevprasesphant (2004)
10.1016/j.ijpharm.2010.08.020
Tight junction modulation by chitosan nanoparticles: comparison with chitosan solution.
D. Vllasaliu (2010)
10.1007/978-1-4612-5182-8_30
Preparation and In Vivo Studies of a New Drug Delivery System
P. Maincent (1984)
10.1007/s11095-004-7675-5
Effect of Pluronic P85 on ATPase Activity of Drug Efflux Transporters
E. Batrakova (2004)
10.1152/AJPGI.1983.245.1.G72
Effect of bile and bile acids on binding of intrinsic factor to cobalamin and intrinsic factor-cobalamin complex to ileal receptor.
B. Seetharam (1983)
10.1016/0378-5173(86)90236-X
Development of a new process for the manufacture of polyisobutylcyanoacrylate nanocapsules
N. A. K. Fallouh (1986)
10.1111/j.1440-1746.1997.tb00395.x
REVIEW: Peyer's patches
K. Heel (1997)
10.1016/S0378-5173(02)00076-5
Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administration.
P. Ahlin (2002)
10.1111/j.2042-7158.1994.tb03854.x
Calcitonin and Insulin in Isobutylcyanoacrylate Nanocapsules: Protection Against Proteases and Effect on Intestinal Absorption in Rats
P. J. Lowe (1994)
10.1002/POLA.1989.080270617
Hydrolysis of alkyl cyanoacrylate and ethoxycarbonylpropenoylphosphonate polymers
A. J. Cooper (1989)
10.1016/j.biomaterials.2010.05.042
Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-responsive nanoparticles vs. subcutaneous injection.
K. Sonaje (2010)
10.1093/clinchem/48.12.2270
Insulin: discovery and controversy.
L. Rosenfeld (2002)
10.1038/nrd2197
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
C. H. Porter (2007)
10.1016/j.addr.2009.11.009
Chitosan-based delivery systems for protein therapeutics and antigens.
M. Amidi (2010)
10.1002/JPS.2600590502
Mechanisms of surfactant effects on drug absorption.
M. Gibaldi (1970)
10.1002/JBM.820110507
Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios.
R. Miller (1977)
10.1016/J.CES.2005.02.057
Nanomilling in stirred media mills
F. Stenger (2005)
10.1016/j.biomaterials.2010.01.042
Enteric-coated capsules filled with freeze-dried chitosan/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery.
K. Sonaje (2010)
Clinical Gastrointestinal Physiology
D. Granger (1985)
10.1016/j.biomaterials.2009.06.055
Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
Lichen Yin (2009)
10.1016/j.jconrel.2008.08.020
Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
Y. Lin (2008)
10.1016/J.IJPHARM.2004.12.025
Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats.
Zengshuan Ma (2005)
10.1021/BM0503165
Exploiting the vitamin B12 pathway to enhance oral drug delivery via polymeric micelles.
M. Francis (2005)
10.1002/JPS.10368
Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin.
R. Cavalli (2003)
10.1016/0378-5173(94)00324-X
Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery
L. Brannon-Peppas (1995)
10.1002/JPS.2600821008
Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism.
B. Aungst (1993)
10.1016/J.BBAMEM.2007.08.017
Transmembrane proteins of tight junctions.
H. Chiba (2008)
10.1038/7385
Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy
K. Roy (1999)
10.1161/HC0202.101988
In Vitro and In Vivo Evaluation of Oral Heparin–Loaded Polymeric Nanoparticles in Rabbits
Y. Jiao (2002)
10.1054/bjoc.2001.2165
Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion
E. Batrakova (2001)
10.1016/0378-5173(94)90371-9
Characterisation of polybutylcyanoarylate nanoparticles: I. Quantification of PCBA polymer and dextrans
K. Langer (1994)
10.1016/j.yrtph.2009.09.015
The safety of chitosan as a pharmaceutical excipient.
P. Baldrick (2010)
10.1016/S0142-9612(03)00331-4
Physico-chemical stability of colloidal lipid particles.
B. Heurtault (2003)
10.1002/JPS.2600570525
Effect of a nonionic surface-active polymer on passage of hydrocortisone across rat intestine in vitro.
W. Saski (1968)
10.1016/J.COPH.2006.05.004
Crossing cellular barriers using dendrimer nanotechnologies.
M. Najlah (2006)
10.1002/JBM.820140202
In vitro heterogeneous degradation of poly(n‐alkyl α‐cyanoacrylates)
W. R. Vezin (1980)
10.1016/S0264-410X(94)80038-2
Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres.
C. Tacket (1994)
10.1016/j.addr.2011.09.010
Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug delivery.
S. Sadekar (2012)
10.1016/J.EJPS.2006.12.006
An improved in vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells.
A. des Rieux (2007)
10.1016/J.JCONREL.2006.05.010
Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability.
Yifan Luo (2006)
10.4155/TDE.11.132
Oral delivery of macromolecules: rationale underpinning Gastrointestinal Permeation Enhancement Technology (GIPET).
E. Walsh (2011)
10.1016/J.JCONREL.2004.08.010
Recent advances on chitosan-based micro- and nanoparticles in drug delivery.
S. Agnihotri (2004)
10.5138/IJDD.2010.0975.0215.02029
Solid lipid nanoparticles in cancer therapy
Vineet Mathur (2010)
10.1016/S0168-3659(02)00087-1
Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers.
M. Elsayed (2002)
10.1211/0022357044959
Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs
L. Hu (2004)
10.1016/j.ijpharm.2007.12.037
Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies.
A. Bayat (2008)
10.1023/A:1016488623022
Mucoadhesive Polymers in Peroral Peptide Drug Delivery. VI. Carbomer and Chitosan Improve the Intestinal Absorption of the Peptide Drug Buserelin In Vivo
H. L. Luessen (2004)
10.1016/J.BIOMATERIALS.2007.01.005
Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles.
I. Bravo-Osuna (2007)
10.1517/17425247.2.5.843
The potential of chitosan for the oral administration of peptides
C. Prego (2005)
10.1016/J.IJPHARM.2006.11.047
In vitro evaluation of dendrimer prodrugs for oral drug delivery.
M. Najlah (2007)
10.1016/J.IJPHARM.2006.02.045
Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals.
R. Mueller (2006)
10.1021/MA035292D
Synthesis and Aggregation Behavior of Pluronic F127/Poly(lactic acid) Block Copolymers in Aqueous Solutions
X. Xiong (2003)
10.1155/2011/865704
Chitosan-Grafted Copolymers and Chitosan-Ligand Conjugates as Matrices for Pulmonary Drug Delivery
Fernanda Andrade (2011)
10.1021/JM00021A015
N-acylated alpha-amino acids as novel oral delivery agents for proteins.
A. Leone-Bay (1995)
10.1016/0378-5173(95)00148-C
Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats
G. Liversidge (1995)
Oral insulin delivery by means of solid lipid nanoparticles
B. Sarmento (2007)
10.1016/S0168-3659(97)00136-3
Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates.
A. Bernkop-Schnürch (1998)
10.1080/10611860410001693706
Issues in Oral Nanoparticle Drug Carrier Uptake and Targeting
A. Florence (2004)
10.1023/A:1011092613951
Intestinal Absorption of Octreotide Using Trimethyl Chitosan Chloride: Studies in Pigs
M. Thanou (2004)
10.1016/S0169-409X(03)00041-3
Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications.
C. Vauthier (2003)
10.1023/A:1016085108889
Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size
M. P. Desai (2004)
Improved peroral delivery of avarol with polybutylcyanoacrylate nanoparticles
P. Beck (1994)
10.2147/NANO.2006.1.2.117
Chitosan nanoparticles for oral drug and gene delivery
Katherine Bowman (2006)
10.1038/nbt0708-729
Poised to branch out
V. Marx (2008)
10.1002/JBM.820060310
Degradation of poly(methyl 2-cyanoacrylates).
C. Wade (1972)
10.1023/A:1007587523543
Anionic PAMAM Dendrimers Rapidly Cross Adult Rat Intestine In Vitro: A Potential Oral Delivery System?
R. Wiwattanapatapee (2004)
10.1007/BF02980249
Pharmaceutical evaluation of genistein-loaded pluronic micelles for oral delivery
Suk Hyung Kwon (2007)
10.1124/jpet.106.107847
Identification of Cell Adhesion Molecules in the Human Follicle-Associated Epithelium That Improve Nanoparticle Uptake into the Peyer's Patches
E. Gullberg (2006)
10.1038/nrd3989
Deal watch: Chiasma and Roche partner in oral peptide drug delivery
C. Harrison (2013)
10.1016/J.EJPB.2007.07.006
Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporation.
R. Mueller (2008)
10.1023/A:1016444808000
Chitosans as Absorption Enhancers for Poorly Absorbable Drugs. 1: Influence of Molecular Weight and Degree of Acetylation on Drug Transport Across Human Intestinal Epithelial (Caco-2) Cells
N. G. Schipper (2004)
10.1016/0378-5173(87)90011-1
Gastrointestinal uptake of liposomes. I. In vitro and in situ studies
Chiang Chia-Ming (1987)
10.1111/j.2042-7158.1991.tb05437.x
The Effect of Site of Administration in the Gastrointestinal Tract on the Absorption of Insulin from Nanocapsules in Diabetic Rats
C. Michel (1991)
10.1016/J.JCONREL.2004.07.030
Transmucosal macromolecular drug delivery.
C. Prego (2005)
10.1016/S0939-6411(00)00087-4
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
10.2174/1389200211309010004
Models to predict intestinal absorption of therapeutic peptides and proteins.
Filipa Antunes (2013)
10.1016/0169-409X(91)90013-3
B) Mechanisms of peptide and protein absorption
H. Nellans (1991)
10.1016/0168-3659(93)90103-C
The preparation of sub-200 nm poly(lactide-co-glycolide) microspheres for site-specific drug delivery
P. Scholes (1993)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar